Schedule 13G ownership disclosure

Anthera Pharmaceuticals Inc (NV)

Security class unavailable · CUSIP: 03674U300

Event date: 2018-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-18-000172
Form type
SC 13G/A
Filer
683 Capital Management, LLC
CIK
CIK 1404574
Filed
Feb 22, 2018
Reporting period
Jan 08, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub